Clinical Trials Browser

telotristat ethyl × 1 year × Clear all

NCT04810091 2026-03-09

Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor

Phase 3 Active not recruiting

79 enrolled 24 charts

Neuroendocrine Tumors

NCT03910387 2025-12-16

Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

Phase 2 Completed

23 enrolled 15 charts

Gastrointestinal

Pancreatic Neoplasms